- Home
- ZYXI vs ABOS Comparison
ZYXI vs ABOS Comparison
Compare ZYXI & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYXI
- ABOS
- Stock Information
- Founded
- ZYXI 1996
- ABOS 1996
- Country
- ZYXI United States
- ABOS United States
- Employees
- ZYXI N/A
- ABOS N/A
- Industry
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- ZYXI Health Care
- ABOS Health Care
- Exchange
- ZYXI Nasdaq
- ABOS Nasdaq
- Market Cap
- ZYXI 72.3M
- ABOS 72.7M
- IPO Year
- ZYXI N/A
- ABOS 2021
- Fundamental
- Price
- ZYXI $2.44
- ABOS $1.24
- Analyst Decision
- ZYXI Buy
- ABOS Strong Buy
- Analyst Count
- ZYXI 3
- ABOS 4
- Target Price
- ZYXI $6.00
- ABOS $6.50
- AVG Volume (30 Days)
- ZYXI 255.9K
- ABOS 563.7K
- Earning Date
- ZYXI 07-24-2025
- ABOS 08-12-2025
- Dividend Yield
- ZYXI N/A
- ABOS N/A
- EPS Growth
- ZYXI N/A
- ABOS N/A
- EPS
- ZYXI N/A
- ABOS N/A
- Revenue
- ZYXI $172,401,000.00
- ABOS N/A
- Revenue This Year
- ZYXI N/A
- ABOS N/A
- Revenue Next Year
- ZYXI $19.55
- ABOS N/A
- P/E Ratio
- ZYXI N/A
- ABOS N/A
- Revenue Growth
- ZYXI N/A
- ABOS N/A
- 52 Week Low
- ZYXI $1.66
- ABOS $0.86
- 52 Week High
- ZYXI $10.62
- ABOS $3.60
- Technical
- Relative Strength Index (RSI)
- ZYXI 51.32
- ABOS 59.32
- Support Level
- ZYXI $2.31
- ABOS $1.12
- Resistance Level
- ZYXI $2.72
- ABOS $1.26
- Average True Range (ATR)
- ZYXI 0.18
- ABOS 0.07
- MACD
- ZYXI -0.00
- ABOS -0.00
- Stochastic Oscillator
- ZYXI 29.81
- ABOS 69.05
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.